Osteoarthritis and Cartilage

• 

  Publication Venue For

  • Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs..  27:571-579. 2019
  • Osteoarthritis year in review 2018: mechanics..  27:392-400. 2019
  • Model-based pain and function outcome trajectory types for patients undergoing knee arthroplasty: a secondary analysis from a randomized clinical trial. 2019
  • Towards prevention of post-traumatic osteoarthritis: report from an international expert working group on considerations for the design and conduct of interventional studies following acute knee injury..  27:23-33. 2019
  • Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial..  26:1658-1665. 2018
  • Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project..  26:1257-1261. 2018
  • Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial..  26:631-640. 2018
  • ASSOCIATION BETWEEN N-CADHERIN, KERATIN-19 AND LUMICAN WITH DISC SPACE NARROWING: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT.  26:S421-S421. 2018
  • YEAR IN REVIEW: MECHANICS.  26:S9-S9. 2018
  • Physical therapy vs internet-based exercise training for patients with knee osteoarthritis: results of a randomized controlled trial..  26:383-396. 2018
  • Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain..  25:1420-1427. 2017
  • Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA..  25:858-865. 2017
  • In vivo biochemical and biomechanical properties of cartilage are affected by obesity..  25:S112-S113. 2017
  • Reply to Stausholm et al.'s letter to the editor regarding our published study entitled, "Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis"..  25:e11-e14. 2017
  • Chondroitin sulphate inhibits NF-κB activity induced by interaction of pathogenic and damage associated molecules..  25:166-174. 2017
  • Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future..  24:2013-2021. 2016
  • Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation..  24:1769-1775. 2016
  • Clinical algorithms to aid osteoarthritis guideline dissemination..  24:1487-1499. 2016
  • Direct in vivo evidence of activated macrophages in human osteoarthritis.  24:1613-1621. 2016
  • Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation..  24:1528-1534. 2016
  • Advances in combining gene therapy with cell and tissue engineering-based approaches to enhance healing of the meniscus..  24:1330-1339. 2016
  • Acute inflammatory response after severe joint injury potentially involved in the development of post-traumatic arthritis.  24:S79-S80. 2016
  • Dynamic joint imaging in human OA: altered in vivo cartilage function and early onset OA.  24:S4-S4. 2016
  • Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance..  24:740-751. 2016
  • Aspartic acid racemization reveals a high turnover state in knee compared with hip osteoarthritic cartilage..  24:374-381. 2016
  • Atlas of radiographic features of osteoarthritis of the ankle and hindfoot..  23:2059-2085. 2015
  • Inflammatory biomarkers in osteoarthritis..  23:1890-1896. 2015
  • Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis..  23:1915-1924. 2015
  • KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study..  23:1674-1684. 2015
  • Non-invasive mouse models of post-traumatic osteoarthritis..  23:1627-1638. 2015
  • Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis.  23:1437-1444. 2015
  • Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis..  23:1437-1444. 2015
  • Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use..  23:1233-1241. 2015
  • Radiographic features of hand osteoarthritis in adult Kashin-Beck Disease (KBD): the Yongshou KBD study..  23:868-873. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis..  23:772-786. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of clinical trials of lifestyle diet and exercise interventions for osteoarthritis..  23:787-797. 2015
  • OARSI Clinical Trials Recommendations: Design and conduct of implementation trials of interventions for osteoarthritis..  23:826-838. 2015
  • OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis..  23:686-697. 2015
  • In vivo strain increases following medial meniscal tear and correlates with synovial fluid matrix metalloproteinase activity.  23:A95-A95. 2015
  • Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments.  23:571-580. 2015
  • Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments..  23:571-580. 2015
  • Joint incongruity and biomarkers of bone metabolism as predictors of post-traumatic arthritis in mice.  23:A242-A243. 2015
  • OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA..  23:550-558. 2015
  • Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study..  23:589-593. 2015
  • Knee osteoarthritis radiographic progression and associations with pain and function prior to knee arthroplasty: a multicenter comparative cohort study..  23:391-396. 2015
  • Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression..  23:70-76. 2015
  • Energy recovery in individuals with knee osteoarthritis..  22:747-755. 2014
  • TSG-6 activity as a novel biomarker of progression in kneeosteoarthritis.  22:235-241. 2014
  • Energy recovery in individuals with knee osteoarthritis.  22:747-755. 2014
  • Osteoarthritis - a case for personalized health care?.  22:7-16. 2014
  • Micromechanical mapping of early osteoarthritic changes in the pericellular matrix of human articular cartilage.  21:1895-1903. 2013
  • Imaging biomarker validation and qualification report: sixth OARSI Workshop on Imaging in Osteoarthritis combined with third OA Biomarkers Workshop..  21:939-942. 2013
  • Prolonged local delivery of IL-1Ra prevents post-traumatic arthritis in mice.  21:S30-S31. 2013
  • A discrete-choice experiment of United Kingdom patients ' willingness to risk adverse events for improved function and pain control in osteoarthritis.  21:289-297. 2013
  • A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis..  21:289-297. 2013
  • High prevalence of contralateral ankle abnormalities in association with knee osteoarthritis and malalignment.  21:1693-1699. 2013
  • Imaging biomarker validation and qualification report: Sixth oarsi workshop on imaging in osteoarthritis combined with third oa biomarkers workshop.  21:939-942. 2013
  • Osteoarthritis and the metabolic syndrome: more evidence that the etiology of OA is different in men and women..  20:603-604. 2012
  • DIO2 modifies inflammatory responses in chondrocytes..  20:440-445. 2012
  • Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254)..  20:271-278. 2012
  • Corrigendum to "Novel synovial fluid recovery method allows for quantification of a marker of arthritis in mice" [Osteoarthritis and Cartilage 2008;16(12): 1532-1538.  20:68. 2012
  • Global metabolic profiling of human osteoarthritic synovium..  20:64-67. 2012
  • Coronal plane ankle alignment, gait, and end-stage ankle osteoarthritis..  19:1338-1342. 2011
  • 1-17 INTRA-ARTICULAR INJECTION OF PURIFIED MESENCHYMAL STEM CELLS FROM C57BL/6 OR MRL/MPJ “SUPERHEALER” MICE PREVENTS POSTTRAUMATIC ARTHRITIS.  19:S5-S5. 2011
  • 142 A UNIQUE DEAMIDATED CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) BIOMARKER PREFERENTIALLY IDENTIFIES HIP OSTEOARTHRITIS.  19:S72-S72. 2011
  • 159 ANALYSIS OF CARTILAGE BIOMARKERS OF TURNOVER AND AGING IN THE OSTEOARTHROPATHY OF ALKAPTONURIA.  19:S80-S80. 2011
  • 177 GAIT COMPENSATIONS IN A RAT MEDIAL MENISCUS TRANSECTION MODEL OF OSTEOARTHRITIS.  19:S88-S89. 2011
  • 181 GAIT ASYMMETRY AFTER MENISCAL TEAR IS ASSOCIATED WITH KNEE PAIN INTENSITY AND FEAR OF MOVEMENT/RE-INJURY.  19:S90-S91. 2011
  • 415 EFFECTS OF SPIN-LOCK TIME SELECTION IN T1RHO RELAXOMETRY.  19:S192-S192. 2011
  • Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee..  19:864-873. 2011
  • Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis..  19:668-675. 2011
  • Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis..  19:515-542. 2011
  • Recommendations of the OARSI FDA Osteoarthritis Devices Working Group..  19:509-514. 2011
  • Osteoarthritis year 2010 in review: biochemical markers..  19:346-353. 2011
  • Response to Letter to the Editor: 'India ink and cartilage'.  19:333-335. 2011
  • Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes..  19:118-125. 2011
  • Summary of the oa biomarkers workshop 2010 - genetics and genomics: New targets in oa.  19:1091-1094. 2011
  • Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project..  18:825-829. 2010
  • Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies..  18:742-745. 2010
  • A comparison of five approaches to measurement of anatomic knee alignment from radiographs..  18:273-277. 2010
  • Racial differences in osteoarthritis pain and function: potential explanatory factors..  18:160-167. 2010
  • Daily pain variations among patients with hand, hip, and knee osteoarthritis..  17:1275-1282. 2009
  • Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project..  17:772-776. 2009
  • Vanilloid receptor TRPV1-mediated phosphorylation of ERK in murine adjuvant arthritis.  17:244-251. 2009
  • Novel synovial fluid recovery method allows for quantification of a marker of arthritis in mice..  16:1532-1538. 2008
  • Re: Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62..  16:1585. 2008
  • Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study..  16:1054-1059. 2008
  • Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis..  16:624-630. 2008
  • Optimization of the fixed-flexion knee radiograph..  15:1221-1224. 2007
  • Measurement of synovial fluid volume using urea..  15:1217-1220. 2007
  • Interleukin-1 and tumor necrosis factor alpha inhibit repair of the porcine meniscus in vitro..  15:1053-1060. 2007
  • Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis..  15:966-971. 2007
  • Erratum to "A longitudinal analysis of serum cytokines in the Hartley guinea pig model of osteoarthritis" [Osteoarthritis Cartilage 15 (2007) 354-356] (DOI:10.1016/j.joca.2006.10.014).  15:848. 2007
  • Relationship of limb length inequality with radiographic knee and hip osteoarthritis..  15:824-829. 2007
  • Response to letter: Static knee alignment and its association with radiographic knee osteoarthritis.  15:846-847. 2007
  • Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample..  15:830-836. 2007
  • A longitudinal analysis of serum cytokines in the Hartley guinea pig model of osteoarthritis..  15:354-356. 2007
  • The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes..  15:120-127. 2007
  • Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression..  15:59-68. 2007
  • Relationship of global assessment of change to AUSCAN and pinch and grip strength among individuals with hand osteoarthritis..  14:1281-1287. 2006
  • Assessment of the utility of biomarkers of osteoarthritis in the guinea pig..  14:923-930. 2006
  • Classification of osteoarthritis biomarkers: a proposed approach..  14:723-727. 2006
  • Viscoelastic properties of zonal articular chondrocytes measured by atomic force microscopy..  14:571-579. 2006
  • The influence of mechanical compression on the induction of osteoarthritis-related biomarkers in articular cartilage explants..  13:1092-1099. 2005
  • The influence of oxygen tension on the induction of nitric oxide and prostaglandin E2 by mechanical stress in articular cartilage..  13:935-941. 2005
  • Identification of an urinary metabolite profile associated with osteoarthritis..  13:762-768. 2005
  • Variation of serum hyaluronan with activity in individuals with knee osteoarthritis..  13:837-840. 2005
  • The effects of cyclic mechanical strain and tumor necrosis factor alpha on the response of cells of the meniscus..  12:956-962. 2004
  • Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee..  12:642-649. 2004
  • Cartilage mechanics in the guinea pig model of osteoarthritis studied with an osmotic loading method..  12:383-388. 2004
  • A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis..  10:758-767. 2002
  • Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway..  10:792-798. 2002
  • Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology..  10:687-691. 2002
  • Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis..  10:707-713. 2002
  • Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis..  9:612-618. 2001
  • The effect of dynamic mechanical compression on nitric oxide production in the meniscus..  9:481-487. 2001
  • The incidence of enlarged chondrons in normal and osteoarthritic human cartilage and their relative matrix density..  8:44-52. 2000
  • Mechanical load stimulates expression of novel genes in vivo and in vitro in avian flexor tendon cells.  7:141-153. 1999
  • Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury..  5:419-426. 1997
  • Isolated chondrons: A viable alternative for studies of chondrocyte metabolism in vitro.  5:261-274. 1997
  • Efficacy of traditional Chinese acupuncture in the treatment of symptomatic knee osteoarthritis: a pilot study.  3:139-142. 1995
  • ARE SERUM CARTILAGE DEGENERATION BIOMARKER CONCENTRATIONS ACCURATE REPRESENTATIONS OF THE INTRA-ARTICULAR ENVIRONMENT OF THE KNEE? 2018
  • ASSESSMENT OF THE SAFETY OF REPEAT ADMINISTRATION OF TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION IN PATIENTS WITH KNEE OSTEOARTHRITIS: TRIAL DESIGN, METHODS AND PRELIMINARY DATA 2018
  • ASSOCIATIONS OF NUMBER OF PHYSICAL THERAPY VISITS AND FREQUENCY OF USE OF AN INTERNET-BASED EXERCISE TRAINING PROGRAM WITH KNEE OSTEOARTHRITIS OUTCOMES 2018
  • BIOMARKERS OF MACROPHAGE-ASSOCIATED INFLAMMATORY PATHWAYS ARE ASSOCIATED WITH OA SYMPTOMS AND RADIOGRAPHIC DISEASE 2018
  • DIFFERENTIAL CARTILAGE TURNOVER ALONG THE HUMAN LOWER LIMB REVEALED BY PROTEIN DEAMIDATION 2018
  • EFFECTS OF SIMULATED MUSCLE EXERCISE ON CHONDROCYTE GENE EXPRESSION IN A 3D-ALGINATE BEAD MODEL SYSTEM 2018
  • FUNCTIONAL FOLATE RECEPTOR CELL-ASSOCIATED INFLAMMATORY CYTOKINES PREDICT THE PROGRESSION OF KNEE OSTEOARTHRITIS 2018
  • IDENTIFYING SUBGROUPS OF PATIENTS WITH DIFFERENTIAL BENEFIT FROM PHYSICAL THERAPY OR INTERNET-BASED EXERCISE TRAINING FOR KNEE OSTEOARTHRITIS 2018
  • OSTEOARTHRITIS CLINICAL TRIAL DESIGN AND FOOD AND DRUG ADMINISTRATION ACCELERATED APPROVAL: LESSONS LEARNED FROM THE OSTEOPOROSIS AND LIVER FIBROSIS FIELDS 2018
  • TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION (TA-ER) PROVIDES CLINICALLY RELEVANT IMPROVEMENTS IN PAIN AND FUNCTION OF KNEE OSTEOARTHRITIS: A POOLED ANALYSIS OF 3 RANDOMIZED CLINICAL TRIALS EMPLOYING COMPOSITE ASSESSMENTS 2018
  • URINARY BIOMARKERS TO NON-INVASIVELY EVALUATE HEALTH IN WILD MOOSE (ALCES ALCES) 2018
  • TSG-6 - a double-edged sword for osteoarthritis (OA). 2018
  • Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). 2018
  • Biomarkers reflect differences in osteoarthritis phenotypes of the lumbar spine: the Johnston County Osteoarthritis Project. 2017
  • An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials 2017
  • Articular fracture upregulates lipid metabolites in human synovial fluid 2017
  • Association of joint hypermobility and lower body osteoarthritis by race 2017
  • Chondrocyte PTH1R anti-hypertrophic signaling is essential for articular cartilage maintenance and protection post trauma 2017
  • Chondroitin Sulphate Inhibits Monocyte Chemoattractant Protein-1 Release from 3T3L1 Adipocytes: A New Treatment Opportunity for Obesity-related Metabolic Syndromes? 2017
  • Functional folate receptor cells within synovium and fluid as therapeutic targets for osteoarthritis 2017
  • Functional genetic polymorphism of IL-1rn encoding the IL-1 receptor antagonist predicts radiographic severity of symptomatic knee OA 2017
  • Identification of biomarkers indicative of synovitis in the mouse articular fracture model of PTA 2017
  • Patient rating of importance of domains of life impact for hand osteoarthritis 2017
  • Quantitative assessment of cartilage remodeling in health and disease 2017
  • Relationship of joint hypermobility with low back pain and lumbar spine osteoarthritis: a pooled analysis of three cross-sectional studies 2017
  • Senescence Indicators are Positively Associated with Severity of Osteoarthritis 2017
  • Direct in vivo evidence of activated macrophages in human osteoarthritis. 2016
  • A big data approach for selection of a large osteoarthritis cohort 2016
  • A proteomic panel predicts drug response to the combination of glucosamine and chondroitin sulfate 2016
  • Association between radiographic severity and pain in knee osteoarthritis 2016
  • Association of synovial fluid inflammatory biomarkers and knee pain 2016
  • Chondroitin sulphate inhibition of NF-κB activity: attentuation of hyaluronan fragment induced inflammatory response in macrophages by chondroitin sulphate is mediated by reduction in NF-κB activity 2016
  • Development of a serum biomarker panel highly predictive of a knee osteoarthritis diagnosis 2016
  • Development of a serum biomarker panel highly predictive of knee osteoarthritis progression 2016
  • Mass spectrometry profiling of non-enzymatic deamidation of articular cartilage components suggests slower protein turnover in deep regions and in hips compared with knees 2016
  • ORAL HYDROLYZED TYPE 1 COLLAGEN INDUCES CHONDROREGENERATION AND INHIBITS SYNOVIAL INFLAMMATION IN MURINE POSTTRAUMATIC OSTEOARTHRITIS 2016
  • Subchondral bone biomarkers as predictors of OA pain progression; linking structural pathology and pain 2016
  • TSG-6 Activity reflects severity of inflammation in knee osteoarthritis and acute joint injury 2016
  • Analysis of cartilage biomarkers of aging and turnover in the osteoarthropathy of alkaptonuria 2015
  • Attentuation of hyaluronan fragment induced inflammatory response in macrophages by chondroitin sulphate 2015
  • Cartilage permeability assessment based on proteomic analysis of plasma protein penetration 2015
  • Characterization of folate receptor beta expression on cells of bone origin 2015
  • Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments 2015
  • N-propeptide of collagen IIA (PIIANP) as a marker of osteoarthritis burden 2015
  • Predictors of lateral compartment joint space difference two or more years after ACL reconstruction: Data from the moon onsite cohort 2015
  • Prevalence and predictors of non-surgical osteoarthritis treatment among patients in primary care clinics 2015
  • Quantitative proteomics of articular cartilage using sequential extraction of transverse cryosections 2015
  • The effect of conditional macrophage depletion on development of injury-induced knee OA in obese transgenic MAFIA mice 2015
  • The relationship between comorbid knee or hip osteoarthritis and healthcare utilization among older adults with new visits for back pain 2015
  • A genome wide association study of pressure pain threshold in the Johnston county osteoarthritis project 2014
  • Effectiveness of internet and DVD decision aids for patients with hip and knee osteoarthritis 2014
  • Hedgehog signaling regulates cholesterol homeostasis in osteoarthritis 2014
  • Heterogeneity of clinical characteristics and treatment use among patients with osteoarthritis in primary care clinics 2014
  • MOON-AAA GCP clinical trial: early lessons from an early interventional trial in patients within 1 week after ACL tear 2014
  • Radiographic subchondral bone trabecular integrity predicts osteoarthritis structural outcomes after anterior cruciate ligament rupture 2014
  • Released macrophage markers as predictors of knee OA progression 2014
  • ASSOCIATIONS OF FREQUENT PREDICTABLE AND UNPREDICTABLE PAIN WITH FUNCTIONAL AND PSYCHOLOGICAL OUTCOMES 2013
  • Association between pain-pressure threshold, low back symptoms and lumbar spine individual radiographic features: the Johnston County Osteoarthritis Project 2013
  • Associations of clinical and biomarker variables with cartilage damage in painful pre-radiographic knee osteoarthritis. results from a population-based study 2013
  • DIRECT ASSESSMENT OF ARTICULAR CARTILAGE AND UNDERLYING SUBCHONDRAL BONE REVEALS A PROGRESSIVE GENE EXPRESSION CHANGE IN HUMAN OSTEOARTHRITIC KNEES 2013
  • Dietary fatty acids differentially affect the development of injury-induced osteoarthritis with diet-induced obesity in mice 2013
  • Glutamate is elevated in pathologic posterior tibial tendons of patients with posterior tibial tendon dysfunction 2013
  • In vivo imaging of NF-кB activity and correlation to pain in a model of inflammatory arthritis 2013
  • In vivo imaging of NF-кB activity and correlation to pain in a model of radiculopathy 2013
  • Mouse models of joint disorders 2013
  • PREDICTORS OF FATIGUE IN PATIENTS WITH HIP AND KNEE OSTEOARTHRITIS 2013
  • Pharmacokinetics of a thermally responsive curcumin conjugate for local antagonism of neuroinflammation in disc herniation 2013
  • SOLUBLE MACROPHAGE BIOMARKERS ARE ASSOCIATED WITH OSTEOARTHRITIS-RELATED KNEE INFLAMMATION 2013
  • STUDY OF DEAMIDATION OF CARTILAGE EXTRACELLULAR MATRIX PROTEINS TO INVESTIGATE CARTILAGE TURNOVER 2013
  • The effects of chondroitin sulphate on inflammasome activation 2013
  • Tunable expression of IL-1Ra in genetically modified mesenchymal stem cells for cartilage tissue engineering 2013
  • Associations between lumbar spine individual radiographic features and knee, hip and hand osteoarthritis: the Johnston County osteoarthritis project 2012
  • BIOMARKERS OF CARTILAGE DEGRADATION AND SYNTHESIS RELEVANT TO KNEE OSTEOARTHRITIS: RELATIONSHIPS WITH DYNAMIC KNEE JOINT LOAD AND CHANGES FOLLOWING EXERCISE 2012
  • DIFFERENCES IN MULTI-JOINT SYMPTOMATIC OSTEOARTHRITIS PHENOTYPES BY RACE AND GENDER: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT 2012
  • Extent of tibiofemoral osteoarthritis prior to knee arthroplasty: multicenter data from the osteoarthritis initiative 2012
  • GENERAL JOINT HYPERMOBILITY AND HIP OSTEOARTHRITIS: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT 2012
  • INFLAMMATORY BIOMARKERS OF OA, IL-6 AND LEPTIN ARE MODIFIABLE IN OVERWEIGHT/OBESE OA PATIENTS WITH A PROTOCOL THAT COMBINES TRAINING IN PAIN COPING SKILLS AND WEIGHT MANAGEMENT 2012
  • PERFORMANCE METRICS OF A NEWLY FORMATTED TYPE II COLLAGEN CLEAVAGE NEO-EPITOPE ASSAY FOR HUMAN URINE: C2C-HUSA 2012
  • XANTHINE OXIDASE RESPONSE IN ACUTE JOINT INJURY 2012
  • 145 ASSOCIATION OF LUMBAR SPINE INDIVIDUAL RADIOGRAPHIC FEATURES WITH URINARY CROSS-LINKED C-TELOPEPTIDE OF TYPE II COLLAGEN (CTX-II) AND SERUM HYALURONAN: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT 2011
  • 342 RACIAL AND GENDER DIFFERENCES IN WILLINGNESS TO UNDERGO TOTAL JOINT REPLACEMENT: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT 2011
  • 495 PAIN COPING SKILLS TRAINING FOR PATIENTS WITH ELEVATED PAIN CATASTROPHIZING WHO ARE SCHEDULED FOR KNEE ARTHROPLASTY: A QUASI-EXPERIMENTAL STUDY 2010
  • A COMPOSITE SCORE OF MULTI-JOINT RADIOGRAPHIC OSTEOARTHRITIS: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT 2010
  • INFLAMMASOME ACTIVATION IN OSTEOARTHRITIS BY URIC ACID 2010
  • INTRAARTICULAR IL1-RA AFTER ACUTE KNEE INJURY DECREASES BIOMARKERS OF INFLAMMATION AND IMPROVES PAIN AND FUNCTION 2010
  • SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN, HYALURONAN, HIGH-SENSITIVITY C-REACTIVE PROTEIN, AND KERATAN SULFATE AS PREDICTORS OF INCIDENT RADIOGRAPHIC KNEE OSTEOARTHRITIS: DIFFERENCES BY CHRONIC KNEE SYMPTOMS 2010
  • URINARY MARKERS, ALPHA CTX AND CTXII, ARE INDICATIVE OF OA SEVERITY AND BONE TURNOVER 2010
  • Altered levels of serum cartilage markers in postmenopausal African-American and caucasian women on current hormone replacement therapy 2004
  • Improved precision of quantitative cartilage measurements with magnetic resonance imaging at 3 T 2004
  • Using epidemiologic studies to identify surrogates for radiographic outcome 2004